From Johns Hopkins Bloomberg School of Public Health—Institute for Health and Productivity Studies (Dr Goetzel) and Truven Health Analytics (Drs Goetzel and Tabrizi), Bethesda, Md; Truven Health Analytics (Dr Henke), Cambridge, Mass; University of Arizona School of Medicine and University of California San Francisco School of Medicine (Dr Pelletier); US Preventive Medicine (Dr Loeppke), Jacksonville, Fla; American Psychological Association (Dr Ballard), Washington, DC; StayWell (Drs Grossmeier and Anderson), St Paul, Minn; The Vitality Institute (Dr Yach), New York, NY; The University of Alabama (Dr Kelly), Tuscaloosa; Mercer (Dr McCalister), Austin, Tex; Optum (Dr Serxner), San Francisco, Calif; Population Health Alliance (Dr Selecky), Washington, DC; Exxon Mobil Corporation (Dr Shallenberger), Houston, Tex; Stanford University School of Medicine (Dr Fries), Palo Alto, Calif; The Dow Chemical Company (Dr Baase), Midland, Mich; Johnson & Johnson (Dr Isaac), New Brunswick; Prudential Financial (Dr Crighton), Newark, NJ; USAA (Dr Wald), San Antonio, Tex; IBM Corporation (Ms Exum), Somers, NY; Cummins, Inc (Dr Shurney), Columbus, Ind; and American Specialty Health (Dr Metz), San Diego, Calif.
Address correspondence to: Ron Z. Goetzel, PhD, Institute for Health and Productivity Studies, Johns Hopkins Bloomberg School of Public Health, and Truven Health Analytics, 7700 Old Georgetown Rd, Ste 650, Bethesda, MD 20814 (ron.goetzel@truvenhealth.com).
Funding for this study was provided by American Specialty Health.
The authors declare no conflicts of interest.
